Close Menu

NEW YORK (360Dx) – Cell-based cancer diagnostics firm Celcuity on Wednesday filed with the US Securities and Exchange Commission for an initial public offering of $15 million.

The Minneapolis-based firm has not priced its shares yet or said how many shares it intends to offer. It plans to list its shares on the Nasdaq under ticker symbol "CELC." Craig-Hallum Capital is the underwriter for the offering.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.